74845-36-6

Upstream product

• 52477-85-7 2-(5-hydroxypentyl)cyclopentanone 
• 52477-93-7 1-methoximino-2-(5-methanesulfonyloxypentyl)-2-cyclopentene 
• 52477-91-5 2-(5-acetoxypentyl)-2-cyclopentenone 
• 52477-93-7 1-methoximino-2-<5-<(methylsulfonyl)oxy>pentyl>-2-cyclopentene 
• 83-13-6 diethyl 2-phenylmalonate 
• 52477-90-4 1-acetoxy-2-(5-acetoxypentyl)-1-cyclopentene 
• 52478-12-3 2-(5-acetoxypentyl)-cyclopentanone 
• 41301-95-5 1-methoximino-2-(5-hydroxypentyl)-2-cyclopentene 
• 52477-92-6 1-methoximino-2-(5-acetoxypentyl)-2-cyclopentene 
• 35074-08-9 2-(4-carboxybutyl)cyclopentan-1-one 
• 41301-70-6 1-acetoxy-2-(4-carbethoxybutyl)cyclopent-1-ene 
• 41301-52-4 2-(4-carbethoxybutyl)cyclopentane-1-one 
• 41301-94-4 1-methoximino-2-(4-carbethoxybutyl)-2-cyclopentene 
• 40098-46-2 2-(4-carbethoxybutyl)cyclopent-2-en-1-one 

Downstream Products

• 74845-37-7 2-(6-carboxy-6-phenylhexyl)-1-methoximino-2-cyclopentene 
• 55756-48-4 2-(6-carbethoxy-6-phenylhexyl)cyclopent-2-en-1-one 
• 74845-35-5 2-(6-carboxy-6-phenylhexyl)cyclopent-2-en-1-one 

Relevant academic research and scientific papers

Hydro substituted prostanoic acids and esters

This disclosure describes certain 11-hydroxy and 11-deoxy-9-keto (or hydroxy)prostanoic acid derivatives useful as bronchodilators, anti-ulcer agents, or as intermediates.

Novel 11-hydroxy-9-keto-5,6-cis-13,14-cis-prostadienoic acid derivatives

This disclosure describes certain 11-hydroxy and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.

Derivatives of 9-hydroxy-13-trans-prostenoic acid

This disclosure describes certain 15-deoxy prostanoic acid derivatives having a hydroxy group further along in the beta-chain, useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.

3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof

This disclosure describes compounds of the class of substituted 9-oxoprostanoic acids and the esters and cationic salts thereof, useful as antimicrobial agents, hypotensive agents, anti-ulcer agents, or as intermediates, and novel processes for preparing the same.

Derivatives of 9-oxo-13-trans-prostenoic acid esters

This disclosure describes homologues, analogues, congeners, and derivatives of 9-oxo-13-trans-prostenoic acid and of 9-hydroxy-13-trans-prostenoic acid, having antimicrobial activity and prostaglandin-like hypotensive activity.

1-Alkoximino-2-(ω-substituted alkyl)-2-cyclopentenes

This disclosure describes certain 1-alkoximino-2-(ω-substituted-alkyl)-2-cyclopentenes useful as intermediates for the preparation of homologues, analogues, congeners, and derivatives of 9-oxo-13-trans-prostenoic acid and of 9-hydroxy-13-trans-prostenoic acid which have antimicrobial activity and prostaglandin-like hypotensive activity.

Lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates

This disclosure describes 3-triphenylmethoxy-1-alkynes, 3-triphenylmethoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.

Hydroxylated 15-deoxy derivatives of 9-hydroxy-13-trans-prostenoic acid

This disclosure describes certain 15-deoxy prostanoic acid derivatives having a hydroxy group further along in the beta-chain, useful as bronchodilators, hypotensive agents, anti-ulcer agents, or as intermediates.

2-Substituted-3,4-epoxycyclopentan-1-ones, and 2-substituted-3,4-epoxycyclopentan-1-ols

This disclosure describes 2-substituted-3,4-epoxy-cyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.